SCHEMBL693858

SCHEMBL693858

CNc1cccc(OC(C)=O)c1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.56
MAPK1 P28482 1/20 0.45
KDM4E B2RXH2 5/20 0.44
HSD17B10 Q99714 3/20 0.44
ALDH1A1 P00352 2/20 0.44
BLM P54132 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
ESR1 P03372 1/20 0.44
ITGB3 P05106 1/20 0.44
ITGA2B P08514 1/20 0.44
HMGB1 P09429 1/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
GGT1 P19440 1/20 0.44
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
NAPRT Q6XQN6 1/20 0.44
TOP1 P11387 4/20 0.43
PTPN1 P18031 1/20 0.43
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5421934 0.84 ACHE (0.54) ACHEMAPK1KDM4EHSD17B10ALDH1A1
SCHEMBL31482993 0.83 PTGS2 (0.53) ACHEMAPK1KDM4EHSD17B10ALDH1A1
SCHEMBL10607461 0.83 PTGS2 (0.53) ACHEMAPK1KDM4EHSD17B10ALDH1A1
SCHEMBL544041 0.82 ACHE (0.69) ACHEMAPK1KDM4EHSD17B10ALDH1A1
SCHEMBL31229899 0.77 ACHE (0.62) ACHEMAPK1KDM4EHSD17B10ALDH1A1
SCHEMBL742810 0.77 ACHE (0.62) ACHEMAPK1KDM4EHSD17B10ALDH1A1
SCHEMBL544172 0.76 ACHE (0.61) ACHEMAPK1KDM4EHSD17B10ALDH1A1
SCHEMBL11585900 0.76 ACHE (0.61) ACHEMAPK1KDM4EHSD17B10ALDH1A1
SCHEMBL907658 0.76 ACHE (0.61) ACHEMAPK1KDM4EHSD17B10ALDH1A1
SCHEMBL544758 0.76 ACHE (0.61) ACHEMAPK1KDM4EHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421849-A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Theravance, Inc. (US) 2012-02-29 EP disclosed